HALOZYME THERAPEUTICS, INC. Goodwill, Acquired During Period
HALOZYME THERAPEUTICS, INC. (HALO) reported Goodwill, Acquired During Period of $163.54 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-02-17
- HALOZYME THERAPEUTICS, INC. goodwill, acquired during period for the quarter ending 2023-03-31 was $7.17M.
- HALOZYME THERAPEUTICS, INC. goodwill, acquired during period for the quarter ending 2022-12-31 was $209.57M.
- HALOZYME THERAPEUTICS, INC. goodwill, acquired during period for the quarter ending 2022-09-30 was $0.00.
- HALOZYME THERAPEUTICS, INC. goodwill, acquired during period for fiscal 2025 was $163.54M.
- HALOZYME THERAPEUTICS, INC. goodwill, acquired during period for fiscal 2022 was $409.05M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | $163.54M 10-K · filed 2026-02-17 | |||
| 2023-03-31 | $7.17M 10-Q · filed 2023-05-09 | $216.74M derived: sum of 2 quarters · filed 2023-05-09 | $216.74M derived: sum of 3 quarters · filed 2023-05-09 | |
| 2022-12-31 | $209.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $209.57M derived: sum of 2 quarters · filed 2023-02-21 | $409.05M 10-K · filed 2023-02-21 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $199.48M 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $199.48M 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |